| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3415247
Max Phase: Preclinical
Molecular Formula: C14H15N3OS
Molecular Weight: 273.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: c1ccc2oc(SCCCCn3ccnc3)nc2c1
Standard InChI: InChI=1S/C14H15N3OS/c1-2-6-13-12(5-1)16-14(18-13)19-10-4-3-8-17-9-7-15-11-17/h1-2,5-7,9,11H,3-4,8,10H2
Standard InChI Key: MYIAGPOPZQOEMK-UHFFFAOYSA-N
Associated Targets(non-human)
Hmox2 Heme oxygenase 2 (264 Activities)
Hmox1 Heme oxygenase 1 (289 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 273.36 | Molecular Weight (Monoisotopic): 273.0936 | AlogP: 3.60 | #Rotatable Bonds: 6 |
| Polar Surface Area: 43.85 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 6.54 | CX LogP: 3.01 | CX LogD: 2.97 |
| Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.51 | Np Likeness Score: -2.12 |
References
| 1. Salerno L, Pittalà V, Romeo G, Modica MN, Marrazzo A, Siracusa MA, Sorrenti V, Di Giacomo C, Vanella L, Parayath NN, Greish K.. (2015) Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines., 96 [PMID:25874340] [10.1016/j.ejmech.2015.04.003] |
Source
Source(1):